Do Faster Drug Approvals Mean More Dangerous Drugs?

Do Faster Drug Approvals Mean More Dangerous Drugs?

Posted By Golomb & Honik || 21-Aug-2014

Passed in 1992, the Prescription Drug Free User Act marked an agreement under which drug manufacturers would help fund the FDA in exchange for faster drug approvals. The intent was to give patients quicker access to potentially helpful experimental drugs. However, a new study suggests the expedition of the drug approval process has led to an increase in the overall number of safety warnings and product recalls.

After the act was passed, Black Box warnings (the FDA’s most serious) and product withdrawals accounted for 26.7 out of every 100 drugs that were approved. Between 1975 and 2009, approximately 34 of every 100 drugs that were placed in a pharmacy would be recalled. Half of those new warnings emerged within the first 12 years following the respective drug’s approval, and the other half emerged within the first five years of the product’s launch.

If you have been harmed as a result of taking a prescribed dangerous drug, you may be entitled to receive compensation for your damages. The experienced attorneys at Golomb & Honik will fight aggressively to ensure your rights are protected every step of the way.

Please contact Golomb & Honik today to schedule your free pharmaceutical injury consultation. We serve clients nationwide from our offices in Philadelphia, Pennsylvania.

Blog Home